Generating synthetic cohorts of real-world patients with metastatic breast cancer to accelerate collaboration

被引：0
|
作者：
Batlle, Marta [1 ]
Sanglier, Thibaut [2 ]
Labaki, Chris [3 ]
Bakouny, Ziad [3 ]
Braun, David A. [4 ]
Bouquet, Fanny [1 ]
Joyce, Maureen Ann [5 ]
Martin, Miguel Valero [1 ]
Xie, Wanling [3 ]
Tolaney, Sara M. [6 ]
Choueiri, Toni K. [3 ]
机构：
[1] F Hoffmann La Roche, Basel, Switzerland
[2] F Hoffmann La Roche Ltd, Basel, Switzerland
[3] Dana Farber Canc Inst, Lank Ctr Genitourinary Oncol, Boston, MA 02115 USA
[4] Yale Sch Med, Yale Canc Ctr, New Haven, CT USA
[5] Genentech Inc, San Francisco, CA USA
[6] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2023年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
874
引用
收藏
页码：408 / 409
页数：2
相关论文
共 50 条
  • [21] Clinical trial participation in real-world patients with metastatic breast cancer: disparities and barriers.
    Tan, Ruoding
    Wang, Rongrong
    Abbass, Ibrahim
    Cassoli, Lourenia
    Mitchell, Edith P.
    CANCER RESEARCH, 2021, 81 (13)
  • [22] REAL-WORLD HEALTHCARE RESOURCE UTILIZATION OF PATIENTS WITH METASTATIC BREAST CANCER: A RETROSPECTIVE COHORT ANALYSIS
    Hanson, K.
    Cha-Silva, A.
    Hull, M.
    DeKoven, M.
    Anupindi, V. R.
    Doshi, R.
    Rocque, G.
    VALUE IN HEALTH, 2023, 26 (06) : S110 - S110
  • [23] Real-world effectiveness outcomes in patients diagnosed with metastatic triple-negative breast cancer
    Skinner, Karen E.
    Haiderali, Amin
    Huang, Min
    Schwartzberg, Lee S.
    FUTURE ONCOLOGY, 2021, 17 (08) : 931 - 942
  • [24] Real-world effectiveness of ribociclib in metastatic breast cancer patients: Does dose affect survival?
    Fernandez-Cuerva, Cristina
    Chinchilla-Alarcon, Teresa
    Jose Alcaraz-Sanchez, Juan
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2023, 29 (07) : 1619 - 1627
  • [25] Chemotherapy-related complication burden in patients with metastatic breast cancer in a real-world setting
    Hurvitz, S. A.
    Lalla, D.
    Guerin, A.
    Latremouille-Viau, D.
    Yu, A. P.
    Wu, E. Q.
    Brammer, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [26] Measures of Outcome in Metastatic Breast Cancer: Insights From a Real-World Scenario
    Bonotto, Marta
    Gerratana, Lorenzo
    Poletto, Elena
    Driol, Pamela
    Giangreco, Manuela
    Russo, Stefania
    Minisini, Alessandro M.
    Andreetta, Claudia
    Mansutti, Mauro
    Pisa, Federica E.
    Fasola, Gianpiero
    Puglisi, Fabio
    ONCOLOGIST, 2014, 19 (06): : 608 - 615
  • [27] A Real-World Efficacy of Nab-Paclitaxel Monotherapy in Metastatic Breast Cancer
    Kim, Jung Sun
    Suh, Koung Jin
    Lee, Dae-Won
    Woo, Go-Un
    Kim, Miso
    Kim, Se Hyun
    Ryu, Han Suk
    Lee, Kyung-Hun
    Kim, Tae-Yong
    Han, Sae-Won
    Park, So Yeon
    Park, In Ae
    Kim, Jee Hyun
    Im, Seock-Ah
    CANCER RESEARCH AND TREATMENT, 2022, 54 (02): : 488 - 496
  • [28] Real-world practice patterns in the management of metastatic breast cancer in Washington State
    Manohar, Poorni
    Linden, Hannah
    Shankaran, Veena
    Fedorenko, Catherine
    Voutsinas, Jenna
    Sun, Qin
    Wu, Vicky
    CANCER RESEARCH, 2023, 83 (05)
  • [29] THE REAL-WORLD COST AND EFFECTIVENESS OF EVEROLIMUS IN METASTATIC BREAST CANCER IN THE CZECH REPUBLIC
    Rihova, B.
    Demlova, R.
    Cerna, R.
    VALUE IN HEALTH, 2018, 21 : S19 - S19
  • [30] Real-world clinical outcomes and toxicity in metastatic breast cancer patients treated with palbociclib and endocrine therapy
    Leticia Varella
    Akaolisa Samuel Eziokwu
    Xuefei Jia
    Megan Kruse
    Halle C. F. Moore
    George Thomas Budd
    Jame Abraham
    Alberto J. Montero
    Breast Cancer Research and Treatment, 2019, 176 : 429 - 434
12345